{
    "2021-06-22": [
        [
            {
                "time": "2020-unknown",
                "orginal_text": "《2020年度药品审评报告》解读：药品审评审批“速”“质”提升 全面利好医药行业发展",
                "features": {
                    "keywords": [
                        "药品审评",
                        "审批速度",
                        "质量提升",
                        "医药行业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "药明康德参股公司Ambryx在纽交所挂牌上市 已被复兴、厚朴投资收购",
                "features": {
                    "keywords": [
                        "药明康德",
                        "Ambryx",
                        "纽交所",
                        "收购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "2700亿疫苗巨头大跌，一大传闻突袭？黄金坑来了？",
                "features": {
                    "keywords": [
                        "疫苗",
                        "大跌",
                        "传闻",
                        "黄金坑"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-14",
                "orginal_text": "复星医药：7月14日举行2021年第二次临时股东大会",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股东大会",
                        "2021"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-22",
                "orginal_text": "A股资金流向（6月22日）：周期股获资金回流，科技题材龙头遭抛售",
                "features": {
                    "keywords": [
                        "A股",
                        "资金流向",
                        "周期股",
                        "科技题材"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "周期股",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "A股收盘综述：医药龙头午后爆发，采掘、银行全天强势",
                "features": {
                    "keywords": [
                        "A股",
                        "医药龙头",
                        "采掘",
                        "银行"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "采掘",
                        "银行"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "医药生物行业周观点：关注行业政策及上半年业绩超预期的企业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业政策",
                        "业绩超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "复星医药AH股齐拉升 研究显示BNT162b2有效率高达93%高于Moderna疫苗",
                "features": {
                    "keywords": [
                        "复星医药",
                        "BNT162b2",
                        "有效率",
                        "Moderna"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "【异动股】复星医药(02196.HK)涨3.48%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "异动股",
                        "涨幅"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "港股复星医药直线拉升，现涨近6%，报57.85港元，其他抗疫概念股不同程",
                "features": {
                    "keywords": [
                        "复星医药",
                        "港股",
                        "拉升",
                        "抗疫概念"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "抗疫"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "疫苗板块午后转暖，复星医药大涨7%",
                "features": {
                    "keywords": [
                        "疫苗",
                        "复星医药",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "unknown",
                "orginal_text": "汉光药业孤儿药获批准上市；勃林格殷格翰精分新药拟纳入突破性治疗；和黄医药索凡替尼获批新适应证",
                "features": {
                    "keywords": [
                        "汉光药业",
                        "孤儿药",
                        "勃林格殷格翰",
                        "和黄医药",
                        "索凡替尼"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}